Nanotechnology Now - Press Release: SWR&D Issued Patent for Nano-Scaled Constructs

Home > Press > SWR&D Issued Patent for Nano-Scaled Constructs

Abstract:
Lawton-based SWR&D, Inc. has been issued a new patent related to their chemotherpeutic delivery technology. The patent, entitled "Magnetically Responsive Nanoparticle Therapeutic Constructs and Methods of Making and Using" involves the bonding of a therapeutic molecule to a magnetic nanoparticle. This construct is introduced into the body then driven to the site within a focused magnetic field.

SWR&D Issued Patent for Nano-Scaled Constructs

Lawton, OK | Posted on March 30th, 2014

"Site-specific delivery of therapeutics has a host of advantages of traditional delivery methods," says Clinton Herring, President and CEO of SWR&D, Inc. "For example, in the treatment of cancer, this technology allows more chemotherapeutic to be delivered to the site while introducing less chemotherapeutic into the body. By doing so, no healthy tissue is affected and patients do not suffer the side effects associated with traditional chemotherapy."

Herring points out that, while the primary focus of this technology has been in the area of chemotherapy, it is being applied to other forms of therapy where site-specific delivery of therapeutics is desired. "This technology has caught the interest of other researchers who are exploring other applications. In fact, we are currently in the process of negotiating a non-exclusive license with a research organization in Oklahoma City."

Other patents related to this technology owned by SWR&D, Inc. include; Device for Moving Magnetic Nanoparticles Through Tissue and Delivery of Bioactive Substances to Target Cells.

####

For more information, please click here

Contacts:
Dennis Donaldson
Senior Vice President
SWR&D, Inc.
102 NE 20th
Lawton, OK 73507
V: 405.706.9687

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: